1. Home
  2. IFBD vs VTGN Comparison

IFBD vs VTGN Comparison

Compare IFBD & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

N/A

Current Price

$1.59

Market Cap

11.0M

Sector

Technology

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

N/A

Current Price

$0.17

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IFBD
VTGN
Founded
2001
1998
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0M
9.5M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
IFBD
VTGN
Price
$1.59
$0.17
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
95.6K
★ 751.6K
Earning Date
05-01-2023
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ N/A
N/A
Revenue This Year
N/A
$33.96
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.66
$0.17
52 Week High
$2.18
$5.14

Technical Indicators

Market Signals
Indicator
IFBD
VTGN
Relative Strength Index (RSI) 70.50 34.95
Support Level $0.81 N/A
Resistance Level $2.12 $0.32
Average True Range (ATR) 0.14 0.01
MACD 0.11 0.00
Stochastic Oscillator 79.16 5.96

Price Performance

Historical Comparison
IFBD
VTGN

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: